Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants

SARS-CoV-2 variants have emerged with elevated transmission and a higher risk of infection for vaccinated individuals. We demonstrate that a recombinant prefusion-stabilized spike (rS) protein vaccine based on Beta/B.1.351 (rS-Beta) produces a robust anamnestic response in baboons against SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Logue, James, Johnson, Robert M., Patel, Nita, Zhou, Bin, Maciejewski, Sonia, Foreman, Bryant, Zhou, Haixia, Portnoff, Alyse D., Tian, Jing-Hui, Rehman, Asma, McGrath, Marisa E., Haupt, Robert E., Weston, Stuart M., Baracco, Lauren, Hammond, Holly, Guebre-Xabier, Mimi, Dillen, Carly, Madhangi, M., Greene, Ann M., Massare, Michael J., Glenn, Greg M., Smith, Gale, Frieman, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972327/
https://www.ncbi.nlm.nih.gov/pubmed/36854666
http://dx.doi.org/10.1038/s41467-022-35606-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972327/
https://www.ncbi.nlm.nih.gov/pubmed/36854666
http://dx.doi.org/10.1038/s41467-022-35606-6

Ejemplares similares